Charles Schwab Investment Management Inc Vir Biotechnology, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 829,311 shares of VIR stock, worth $7.38 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
829,311
Previous 753,073
10.12%
Holding current value
$7.38 Million
Previous $7.58 Million
10.89%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding VIR
# of Institutions
225Shares Held
88.2MCall Options Held
177KPut Options Held
182K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$148 Million1.67% of portfolio
-
Black Rock Inc. New York, NY16.6MShares$147 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$110 Million0.0% of portfolio
-
State Street Corp Boston, MA7.07MShares$62.9 Million0.0% of portfolio
-
Baillie Gifford & CO3.95MShares$35.1 Million0.03% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.18B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...